IncellDx this week announced it has hired Keith Shults as director of research and development.
Previously Shults was the director of advanced cytometric applications at Nodality. Before that he co-founded Cytometry Associates, which was subsequently purchased by Esoterix, where he was vice president of technology transfer within the company's Center for Innovation.